Ventyx Biosciences Stock Working Capital

VTYX Stock

USD 2.02 0.13 6.88%

Ventyx Biosciences fundamentals help investors to digest information that contributes to Ventyx Biosciences' financial success or failures. It also enables traders to predict the movement of Ventyx Stock. The fundamental analysis module provides a way to measure Ventyx Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ventyx Biosciences stock.

	Last Reported	Projected for Next Year
Net Working Capital	278.4 M	177.3 M
Change In Working Capital	6.7 M	7 M

Change In Working Capital is likely to rise to about 7 M in 2025, whereas Net Working Capital is likely to drop slightly above 177.3 M in 2025.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Ventyx Biosciences Company Working Capital Analysis

Ventyx Biosciences' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Working Capital

Current Assets

-

Current Liabilities

More About Working Capital | All Equity Analysis

Current Ventyx Biosciences Working Capital

242.08 M

Most of Ventyx Biosciences' fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ventyx Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Ventyx Working Capital Driver Correlations

Understanding the fundamental principles of building solid financial models for Ventyx Biosciences is extremely important. It helps to project a fair market value of Ventyx Stock properly, considering its historical fundamentals such as Working Capital. Since Ventyx Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ventyx Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ventyx Biosciences' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Net Receivables	Capital Surpluse	Common Stock	Property Plant Equipment	Short Term Debt
Total Assets		0.21	0.76	-0.95	-0.86	0.99	0.86	0.68	1.0	1.0	1.0	0.62	0.84	0.8	0.84	0.61
Total Stockholder Equity	0.21		0.6	-0.06	-0.66	0.31	0.23	0.56	0.18	0.24	0.22	0.89	0.54	0.63	0.53	0.86
Net Tangible Assets	0.76	0.6		-0.6	-0.93	0.81	0.62	0.72	0.74	0.77	0.76	0.87	0.95	0.96	0.95	0.81
Net Debt	-0.95	-0.06	-0.6		0.73	-0.91	-0.76	-0.5	-0.97	-0.95	-0.95	-0.46	-0.65	-0.62	-0.66	-0.42
Retained Earnings	-0.86	-0.66	-0.93	0.73		-0.9	-0.78	-0.83	-0.83	-0.87	-0.86	-0.92	-0.93	-0.93	-0.93	-0.87
Accounts Payable	0.99	0.31	0.81	-0.91	-0.9		0.89	0.78	0.98	0.99	0.99	0.69	0.89	0.85	0.9	0.69
Long Term Debt	0.86	0.23	0.62	-0.76	-0.78	0.89		0.9	0.83	0.86	0.86	0.57	0.74	0.7	0.74	0.6
Total Liab	0.68	0.56	0.72	-0.5	-0.83	0.78	0.9		0.64	0.7	0.69	0.76	0.8	0.79	0.8	0.79
Net Invested Capital	1.0	0.18	0.74	-0.97	-0.83	0.98	0.83	0.64		1.0	1.0	0.58	0.82	0.77	0.82	0.58
Total Current Assets	1.0	0.24	0.77	-0.95	-0.87	0.99	0.86	0.7	1.0		1.0	0.64	0.85	0.81	0.85	0.64
Net Working Capital	1.0	0.22	0.76	-0.95	-0.86	0.99	0.86	0.69	1.0	1.0		0.62	0.84	0.8	0.85	0.62
Net Receivables	0.62	0.89	0.87	-0.46	-0.92	0.69	0.57	0.76	0.58	0.64	0.62		0.83	0.89	0.82	0.95
Capital Surpluse	0.84	0.54	0.95	-0.65	-0.93	0.89	0.74	0.8	0.82	0.85	0.84	0.83		0.98	1.0	0.86
Common Stock	0.8	0.63	0.96	-0.62	-0.93	0.85	0.7	0.79	0.77	0.81	0.8	0.89	0.98		0.98	0.91
Property Plant Equipment	0.84	0.53	0.95	-0.66	-0.93	0.9	0.74	0.8	0.82	0.85	0.85	0.82	1.0	0.98		0.85
Short Term Debt	0.61	0.86	0.81	-0.42	-0.87	0.69	0.6	0.79	0.58	0.64	0.62	0.95	0.86	0.91	0.85

Click cells to compare fundamentals

Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.

Competition

Predict Ventyx Biosciences

Working Capital Over Time

Ventyx Net Invested Capital

Net Invested Capital

188.92 Million

At this time, Ventyx Biosciences' Net Invested Capital is fairly stable compared to the past year.

As per the company's disclosures, Ventyx Biosciences has a Working Capital of 242.08 M. This is 43.13% lower than that of the Pharmaceuticals sector and 55.06% lower than that of the Health Care industry. The working capital for all United States stocks is 83.62% higher than that of the company.

Ventyx Working Capital Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ventyx Biosciences' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ventyx Biosciences could also be used in its relative valuation, which is a method of valuing Ventyx Biosciences by comparing valuation metrics of similar companies.

Ventyx Biosciences is currently under evaluation in working capital category among its peers.

Ventyx Biosciences ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Ventyx Biosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Ventyx Biosciences' managers, analysts, and investors.

Environmental

Governance

Social

Ventyx Fundamentals

	Return On Equity	-0.54
	Return On Asset	-0.33
	Current Valuation	(120.95 M)
	Shares Outstanding	70.71 M
	Shares Owned By Insiders	4.40 %
	Shares Owned By Institutions	84.63 %
	Number Of Shares Shorted	9.6 M
	Price To Book	0.51 X
	EBITDA	(207.84 M)
	Net Income	(192.96 M)
	Cash And Equivalents	250.45 M
	Cash Per Share	4.92 X
	Total Debt	12.51 M
	Debt To Equity	0.01 %
	Current Ratio	14.27 X
	Book Value Per Share	3.94 X
	Cash Flow From Operations	(166.52 M)
	Short Ratio	5.10 X
	Earnings Per Share	(2.35) X
	Target Price	12.0
	Number Of Employees	75
	Beta	0.37
	Market Capitalization	142.84 M
	Total Asset	277.69 M
	Retained Earnings	(419.19 M)
	Working Capital	242.08 M
	Net Asset	277.69 M

About Ventyx Biosciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Ventyx Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ventyx Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ventyx Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

Additional Tools for Ventyx Stock Analysis

When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC